Evaluation of Serum and Urine Levels of Matrix Metalloproteinase (MMP-2) in Children with Nephrotic Syndrome
1
Department of Chemistry and Biochemistry, College of Medicine, AL- Nahrain University, Iraq
2
Departments of Internal Medicine, College of Medicine, AL- Nahrain University, Iraq
Submission date: 2024-03-05
Final revision date: 2025-02-09
Acceptance date: 2025-04-24
Publication date: 2025-07-25
Corresponding author
Tulba Abdul Saahib Hameed
Department of Chemistry and Biochemistry, College of Medicine, AL- Nahrain University, Baghdad, Iraq
Department of Chemistry and Biochemistry, College of Medicine, AL- Nahrain University, Baghdad, Iraq
Wiadomości Lekarskie 2025;(6)
KEYWORDS
TOPICS
ABSTRACT
Aim:
To Evaluate the Serum and Urine Levels of Matrix Metalloproteinase (MMP-2) in Children with Nephrotic Syndrome.
Material and methods:
This study was conducted at Pediatric Nephrology consultation Clinic in Al Imamain Kadhimain Medical City, Ibn Balady Children and Maternity Hospital, Child Central Teaching Hospital, Baghdad, Iraq and Children Welfare Teaching Hospital/Medical City Complex from 1st of November 2021 to 31th of March 2022 and included 60 Patients who are children with NS , and 60 healthy children age and sex matched as a control group Patients with NS were admitted to pediatric ward or attending the pediatric Nephrology clinic.
Results:
We found there was no significant difference in age and gender between the three groups, healthy controls, SSNS and SRNS. However, SRNS had significantly higher mean SBP and DBP (123.0±15.79 mmHg and 79.97±12.44mmHg, respectively) than either SSNS patients (109.58±13.08 mmHg and 73.5±11.31mmHg, respectively) or controls (99.75±9.23 mmHg and 65.58±5.83 mmHg, respectively).
Conclusions:
There was no significant difference in age and gender between the three groups, healthy controls, SSNS and SRNS However, SRNS had significantly higher mean SBP and DBP, However, ACE, cyclosporine and MMF were more common among patients with SRNS For MMP-2 the results found serum MMP-2 and urine MMP-2 was significantly higher in SSNS patients SRNS patients.
To Evaluate the Serum and Urine Levels of Matrix Metalloproteinase (MMP-2) in Children with Nephrotic Syndrome.
Material and methods:
This study was conducted at Pediatric Nephrology consultation Clinic in Al Imamain Kadhimain Medical City, Ibn Balady Children and Maternity Hospital, Child Central Teaching Hospital, Baghdad, Iraq and Children Welfare Teaching Hospital/Medical City Complex from 1st of November 2021 to 31th of March 2022 and included 60 Patients who are children with NS , and 60 healthy children age and sex matched as a control group Patients with NS were admitted to pediatric ward or attending the pediatric Nephrology clinic.
Results:
We found there was no significant difference in age and gender between the three groups, healthy controls, SSNS and SRNS. However, SRNS had significantly higher mean SBP and DBP (123.0±15.79 mmHg and 79.97±12.44mmHg, respectively) than either SSNS patients (109.58±13.08 mmHg and 73.5±11.31mmHg, respectively) or controls (99.75±9.23 mmHg and 65.58±5.83 mmHg, respectively).
Conclusions:
There was no significant difference in age and gender between the three groups, healthy controls, SSNS and SRNS However, SRNS had significantly higher mean SBP and DBP, However, ACE, cyclosporine and MMF were more common among patients with SRNS For MMP-2 the results found serum MMP-2 and urine MMP-2 was significantly higher in SSNS patients SRNS patients.
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
